Quantitative profiling of Human renal UDP-glucuronosyltransferases and glucuronidation activity: A comparison of normal and tumoral kidney tissues

Drug Metabolism and Disposition

Volumn 43, Issue 4, 2015, Pages 611-619

  Margaillan, Guillaume ^a   Rouleau, Michèle ^a   Fallon, John K ^b   Caron, Patrick ^a   Villeneuve, Lyne ^a   Turcotte, Véronique ^a   Smith, Philip C ^b   Joy, Melanie S ^c   Guillemette, Chantal ^a  

^a Université Laval   (Canada)

^b University of North Carolina   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; DEFERIPRONE; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A9; GLUCURONOSYLTRANSFERASE 2B7; MESSENGER RNA; MYCOPHENOLIC ACID; PROPOFOL; SORAFENIB; TACROLIMUS; ZIDOVUDINE; DRUG; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; UDP-GLUCURONOSYLTRANSFERASE 1A9; UDP-GLUCURONOSYLTRANSFERASE, UGT1A6; UGT2B7 PROTEIN, HUMAN;

ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY TUMOR; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; ENZYMOLOGY; GENETICS; KIDNEY; KIDNEY CARCINOMA; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

CARCINOMA, RENAL CELL; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; PHARMACEUTICAL PREPARATIONS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84939787008     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.114.062877     Document Type: Article

References (36)

1. Anders MW (1980) Metabolism of drugs by the kidney. Kidney Int 18:636-647.
2. Bélanger A.S., Caron P, Harvey M., Zimmerman PA, Mehlotra RK, and Guillemette C (2009) Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine. Drug Metab Dispos 37:1793-1796.
3. Bellemare J, Rouleau M, Harvey M., Popa I, Pelletier G, Têtu B, and Guillemette C (2011) Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans. J Pathol 223:425-435.
4. Benoit-Biancamano M.O., Connelly J, Villeneuve L., Caron P, and Guillemette C (2009) Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants. Drug Metab Dispos 37:322-329.
5. Chu XY, Liang Y, Cai X., Cuevas-Licea K, Rippley RK, Kassahun K, Shou M., Braun MP, Doss GA, and Anari MR, et al. (2009) Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transporters. Pharm Res 26:459-468.
6. Court MH, Zhang X, Ding X., Yee KK, Hesse LM, and Finel M (2012) Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica 42:266-277.
7. Dellinger RW, Matundan HH, Ahmed A.S., Duong PH, and Meyskens FL, Jr (2012) Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells. PLoS ONE 7: e47696.
8. Escudier B, Eisen T, Stadler W.M., Szczylik C., Oudard S, Siebels M, Negrier S., Chevreau C, Solska E, and Desai AA, et al.; TARGET Study Group (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125-134.
9. Fallon JK, Neubert H, Goosen T.C., and Smith PC (2013a) Targeted precise quantification of 12 human recombinant uridine-diphosphate glucuronosyl transferase 1A and 2B isoforms using nano-ultra-high-performance liquid chromatography/tandem mass spectrometry with selected reaction monitoring. Drug Metab Dispos 41:2076-2080.
10. Fallon JK, Neubert H, Hyland R., Goosen TC, and Smith PC (2013b) Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using NanoUPLC-MS/MS with selected reaction monitoring. J Proteome Res 12:4402-4413.
11. Gaganis P, Miners JO, Brennan J.S., Thomas A., and Knights KM (2007) Human renal cortical and medullary UDP-glucuronosyltransferases (UGTs): immunohistochemical localization of UGT2B7 and UGT1A enzymes and kinetic characterization of S-naproxen glucuronidation. J Pharmacol Exp Ther 323:422-430.
12. Gruber M, Bellemare J, Hoermann G., Gleiss A, Porpaczy E, Bilban M., Le T, Zehetmayer S, Mannhalter C., and Gaiger A, et al. (2013) Overexpression of uridine diphospho glucur-onosyltransferase 2B17 in high-risk chronic lymphocytic leukemia. Blood 121:1175-1183.
13. Guillemette C, Lévesque É, and Rouleau M (2014) Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications. Clin Pharmacol Ther 96:324-339.
14. Gundert-Remy U., Bernauer U, Blömeke B, Döring B, Fabian E., Goebel C, Hessel S, Jäckh C, Lampen A., and Oesch F, et al. (2014) Extrahepatic metabolism at the body's internal-external interfaces. Drug Metab Rev 46:291-324.
15. Harbourt DE, Fallon JK, Ito S, Baba T., Ritter JK, Glish GL, and Smith PC (2012) Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry. Anal Chem 84: 98-105.
16. Keating GM and Santoro A (2009) Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs 69:223-240.
17. Knights KM and Miners JO (2010) Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators. Drug Metab Rev 42:63-73.
18. Knights KM, Rowland A, and Miners JO (2013) Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). Br J Clin Pharmacol 76:587-602.
19. Lépine J., Audet-Walsh E, Grégoire J, Têtu B, Plante M., Ménard V, Ayotte P., Brisson J, Caron P, and Villeneuve L, et al. (2010) Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways. J Clin Endocrinol Metab 95:2689-2698.
20. Lépine J., Bernard O, Plante M., Têtu B, Pelletier G., Labrie F, Bélanger A, and Guillemette C (2004) Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 89:5222-5232.
21. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
22. McGurk KA, Brierley CH, and Burchell B (1998) Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochem Pharmacol 55:1005-1012.
23. Ménard V., Lévesque E, Chen S., Eap O, Joy MS, Ekström L, Rane A., and Guillemette C (2013) Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer. Pharmacogenet Genomics 23:684-696.
24. Nakamura A, Nakajima M, Yamanaka H., Fujiwara R, and Yokoi T (2008) Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461-1464.
25. Ohno S and Nakajin S (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by realtime reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32-40.
26. Sato Y, Nagata M, Kawamura A., Miyashita A, and Usui T (2012) Protein quantification of UDP-glucuronosyltransferases 1A1 and 2B7 in human liver microsomes by LC-MS/MS and correlation with glucuronidation activities. Xenobiotica 42:823-829.
27. Sato Y, Nagata M, Tetsuka K., Tamura K, Miyashita A, Kawamura A., and Usui T (2014) Optimized methods for targeted peptide-based quantification of human uridine 5'-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry. Drug Metab Dispos 42:885-889.
28. Shipkova M, Strassburg CP, Braun F, Streit F., Gröne HJ, Armstrong V.W., Tukey RH, Oellerich M, and Wieland E (2001) Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Pharmacol 132:1027-1034.
29. Starlard-Davenport A., Lyn-Cook B, and Radominska-Pandya A (2008) Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene. Steroids 73: 139-147.
30. Strassburg CP, Manns MP, and Tukey RH (1997) Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res 57:2979-2985.
31. Sutherland L, Ebner T, and Burchell B (1993) The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. Biochem Pharmacol 45:295-301.
32. Thibaudeau J, Lépine J, Tojcic J., Duguay Y, Pelletier G, Plante M., Brisson J, Têtu B, Jacob S., and Perusse L, et al. (2006) Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estra-diol and estrone. Cancer Res 66:125-133.
33. Yan T, Gao S, Peng X., Shi J, Xie C, Li Q., Lu L, Wang Y, Zhou F., and Liu Z, et al. (2014) Significantly decreased and more variable expression of major cyps and ugts in liver microsomes prepared from HBV-positive human hepatocellular carcinoma and matched peri-carcinomatous tissues determined using an isotope label-free UPLC-MS/MS method. Pharm Res, in press.
34. Ye L, Yang X, Guo E., Chen W, Lu L, Wang Y., Peng X, Yan T, Zhou F., and Liu Z (2014) Sorafenib metabolism is significantly altered in the liver tumor tissue of hepatocellular carcinoma patient. PLoS ONE 9:e96664.
35. Zahreddine HA, Culjkovic-Kraljacic B, Assouline S., Gendron P, Romeo AA, Morris S.J., Cormack G., Jaquith JB, Cerchietti L, and Cocolakis E, et al. (2014) The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation. Nature 511:90-93.
36. Zustovich F, Lombardi G, Pastorelli D., Farina P, Bianco MD, De Zorzi L, Palma MD, Nicoletto O, and Zagonel V (2011) Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. Open Access J Urol 3:69-82.